PT  - JOURNAL ARTICLE
AU  - Wood, A.J.
AU  - Sanchez, A.R.
AU  - Bessell, P.R.
AU  - Wightman, R.
AU  - Kao, R.R.
TI  - Assessing the importance of demographic risk factors across two waves of SARS-CoV-2 using fine-scale case data
AID  - 10.1101/2022.08.03.22278013
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2022.08.03.22278013
4099  - http://medrxiv.org/content/early/2023/09/08/2022.08.03.22278013.short
4100  - http://medrxiv.org/content/early/2023/09/08/2022.08.03.22278013.full
AB  - For the long term control of an infectious disease such as COVID-19, it is crucial to identify the most likely individuals to become infected and the role that differences in demographic characteristics play in the observed patterns of infection. As high-volume surveillance winds down, testing data from earlier periods are invaluable for studying risk factors for infection in detail. Observed changes in time during these periods may then inform how stable the pattern will be in the long term.To this end we analyse the distribution of cases of COVID-19 across Scotland in 2021, where the location (census areas of order 500–1,000 residents) and reporting date of cases are known. We consider over 450,000 individually recorded cases, in two infection waves triggered by different lineages: B.1.1.529 (“Omicron”) and B.1.617.2 (“Delta”). We use random forests, informed by measures of geography, demography, testing and vaccination. We show that the distributions are only adequately explained when considering multiple explanatory variables, implying that case heterogeneity arose from a combination of individual behaviour, immunity, and testing frequency.Despite differences in virus lineage, time of year, and interventions in place, we find the risk factors remained broadly consistent between the two waves. Many of the observed smaller differences could be reasonably explained by changes in control measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been funded by the ESRC grant "Real-time monitoring and predictive modelling of the impact of human behaviour and vaccine characteristics on COVID-19 vaccination in Scotland" (ES/W001489/1). This work has also been funded the BBSRC Institute Strategic Programme grant to the Roslin Institute (BB/J004235/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes